Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Statins reduce hepatocellular carcinoma risk in cirrhotic patients Statins reduce hepatocellular carcinoma risk in cirrhotic patients

Statins reduce hepatocellular carcinoma risk in cirrhotic patients

17 Nov 2021

The risk of hepatocellular carcinoma (HCC) among patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis is low, reveals a recent study. In addition, dose-dependent statin can substantially lower the risk of HCC in patients with NASH cirrhosis.

17 Nov 2021